NCT04477096View on ClinicalTrials.gov

Evaluation of Drug Interaction Between HS-10234 and Emtriccitabine

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 3, 2020

Primary Completion Date

September 24, 2020

Study Completion Date

September 24, 2020

Conditions
Healthy Subjects
Interventions
DRUG

HS-10234

HS-10234

DRUG

Emtricitabine

Emtricitabine

Trial Locations (1)

410013

Xiangya Hospital, Central South University, Changsha

Sponsors
All Listed Sponsors
lead

Jiangsu Hansoh Pharmaceutical Co., Ltd.

INDUSTRY

NCT04477096 - Evaluation of Drug Interaction Between HS-10234 and Emtriccitabine | Biotech Hunter | Biotech Hunter